Funding

neuroClues closes €10M Series A, bringing total funding to €25M

neuroClues, a MedTech company developing quantitative tools for neurological assessment, announced the close of a €10 million Series A financing round. The investment brings the...

Lifebloom secures €8M for exoskeleton walking therapy

French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....

HEPTA Medical closes a €10M oversubscribed Series A

HEPTA MEDICAL, a medical technology company developing a minimally invasive treatment for early-stage lung cancer, announced the closing of its €10 million oversubscribed Series...

Mediwhale secures $13.1M in Series C funding, preparing for IPO

Medical AI company Mediwhale said it completed a 20 billion won ($13.1 million) Series C funding round. Premier Partners led the investment, with KB Investment,...

StairMed raises $73М to advance BMI and DBS system development

China’s StairMed Technology has raised RMB 500 million ($72.7m) to advance its brain-machine interface (BMI) and deep-brain stimulation (DBS) technologies to advance treatment options...

Lucida Medical raises £8.7M to power ‘same day’ cancer diagnosis

IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and...

Virchow raises $4M to advance biopsy stewardship and precision oncology access

Virchow Medical, manufacturer of the Crow’s Nest® Biopsy Catchment System and operator of the Virchow VaultTM Liquid Specimen Biorepository, announced it has completed a...

Vaxess rebrands to Terrestrial Bio, raises $50M for GLP-1 patch

Vaxess Technologies announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing. Boston-based Terrestrial Bio rebranded to reflect its strategic...

Endogenex raises $50M to advance type 2 diabetes treatment

Endogenex has raised $50m in funding, setting the company up with sufficient funds to complete a pivotal trial of its type 2 diabetes (T2D)...
1...345...127Page 4 of 127

Latest articles